Dr. Kyle Greenway discusses his Montreal Model for ketamine-assisted therapy, highlighting the need for active therapy alongside ketamine. The podcast explores diverse effects of ketamine, differences between ketamine and esketamine, contraindications with GABA agonists, and tapering off benzodiazepines during therapy.

Kyle Greenway, who developed the Montreal Model for ketamine and psychotherapy, discusses setting personalized therapeutic goals, exploring thought diffusion, the relationship between values and behavior in therapy, setting goals for ketamine treatment, and the therapeutic power of music in therapy.

Kyle Greenway, developer of the Montreal Model for ketamine therapy, discusses the essential steps in preparing for ketamine-assisted therapy, rationalizing medication regimens, building a collaborative relationship, creating a supportive environment, and integrating music and personal items in psychedelic therapy.